Lisa Gill
Stock Analyst at JP Morgan
(3.49)
# 886
Out of 5,090 analysts
133
Total ratings
51.61%
Success rate
4.46%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Overweight | $32 → $33 | $23.84 | +38.42% | 6 | Nov 13, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $6 → $5 | $2.71 | +84.50% | 2 | Nov 11, 2025 | |
| PGNY Progyny | Maintains: Neutral | $25 → $26 | $24.02 | +8.24% | 1 | Nov 11, 2025 | |
| COR Cencora | Maintains: Overweight | $344 → $417 | $339.66 | +22.77% | 3 | Nov 11, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $291 → $317 | $258.39 | +22.68% | 2 | Nov 7, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $17 → $18 | $19.55 | -7.93% | 5 | Nov 5, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $428 → $375 | $265.44 | +41.27% | 14 | Nov 4, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $384 → $394 | $330.75 | +19.12% | 6 | Oct 28, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $310 → $425 | $330.91 | +28.43% | 10 | Oct 9, 2025 | |
| MCK McKesson | Maintains: Overweight | $821 → $853 | $808.62 | +5.49% | 14 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $9.31 | +7.41% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $7 → $6 | $2.59 | +131.66% | 5 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $182.51 | +4.10% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $19.47 | +54.08% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $29.89 | +37.17% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $257.85 | -0.72% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $81 | $75.63 | +7.10% | 5 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $142 → $145 | $198.83 | -27.07% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $30.76 | -41.48% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $5.03 | -0.60% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $17.19 | +62.89% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $7.59 | +18.58% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $8.79 | +104.78% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $151.86 | +160.11% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $231.08 | -19.51% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $210.00 | -33.33% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $486.70 | -31.79% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.65 | +1,279.94% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $6.48 | +23.46% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $73.62 | +12.74% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $38.34 | +155.61% | 1 | Jan 6, 2023 |
Privia Health Group
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $23.84
Upside: +38.42%
GoodRx Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.71
Upside: +84.50%
Progyny
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $24.02
Upside: +8.24%
Cencora
Nov 11, 2025
Maintains: Overweight
Price Target: $344 → $417
Current: $339.66
Upside: +22.77%
Labcorp Holdings
Nov 7, 2025
Maintains: Overweight
Price Target: $291 → $317
Current: $258.39
Upside: +22.68%
Alignment Healthcare
Nov 5, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $19.55
Upside: -7.93%
The Cigna Group
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $265.44
Upside: +41.27%
Elevance Health
Oct 28, 2025
Maintains: Overweight
Price Target: $384 → $394
Current: $330.75
Upside: +19.12%
UnitedHealth Group
Oct 9, 2025
Maintains: Overweight
Price Target: $310 → $425
Current: $330.91
Upside: +28.43%
McKesson
Sep 26, 2025
Maintains: Overweight
Price Target: $821 → $853
Current: $808.62
Upside: +5.49%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $9.31
Upside: +7.41%
Aug 27, 2025
Maintains: Underweight
Price Target: $7 → $6
Current: $2.59
Upside: +131.66%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $182.51
Upside: +4.10%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $19.47
Upside: +54.08%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $29.89
Upside: +37.17%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $257.85
Upside: -0.72%
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $75.63
Upside: +7.10%
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $198.83
Upside: -27.07%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $30.76
Upside: -41.48%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $5.03
Upside: -0.60%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $17.19
Upside: +62.89%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $7.59
Upside: +18.58%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $8.79
Upside: +104.78%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $151.86
Upside: +160.11%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $231.08
Upside: -19.51%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $210.00
Upside: -33.33%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $486.70
Upside: -31.79%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.65
Upside: +1,279.94%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $6.48
Upside: +23.46%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $73.62
Upside: +12.74%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $38.34
Upside: +155.61%